Jcyte, Inc
jCyte is a clinical-stage company focused on the application of progenitor cell-based technology in retinal diseases. The Company's allogeneic product candidate, jCell, is delivered by simple intravitreal injection without the need for surgery or immune suppression. jCyte has completed a phase 1/2a, phase 1/2a extension and phase 2b clinical trials testing jCell in patients with Retinitis Pigmentosa.
7-day free trial · no credit card
Verified contacts
10
available on Kipplo
LinkedIn employees
11
1 to 10 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
1
tools in use
Monthly traffic
208
organic / mo
Sign up free to see all 10 verified contacts at Jcyte, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
10 contacts with verified email or phone · masked until revealed.
- JP
John Pollack
Chief Medical Officer · Healthcare & Human Services
EmailPhone - JS
John Sholar
Chief Executive Officer · General Business & Management
EmailPhone - RB
Rob Beathard
Chief Strategy Officer · Other
EmailPhone - VC
Victor Chao
Vice President Commercial Strategy and Operations · Other
EmailPhone - AW
Adam Walsh
Chief Financial Officer · Other
EmailPhone - JY
Jing Yang
Ø - · Other
EmailPhone
Showing 6 of 10 verified contacts
Top roles at Jcyte, Inc
7 distinct titles indexed · top 7 shown.
- 1chief executive officer
- 1chief financial officer
- 1chief medical officer
- 1chief strategy officer
- 1director of finance
- 1vice president commercial strategy and operations
- 1ø -
Sign up to unlock all 10 contacts at Jcyte, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 10 verified contacts at Jcyte, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.